Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

Incyte reports new KRAS G12D and bispecific antibody data across pancreatic and colorectal cancer


Olomorasib shows durable first-line activity in KRAS G12C-mutant lung cancer


RYBREVANT FASPRO combination shows 77% response rate in first-line advanced head and neck cancer


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

A risk based approach to continuous processing

Presented by Rob Bowen, Chair of the UK Central Region of ISPE and co-chair of the ISPE HVAC and Sustainable Facilities Community of Practice.Process Architect and Director,Facilities Integration
14th May 2015


Sanofi’s Journey & Strategy for Continuous Processing for Small Molecules

Presented by Flavien Susanne, Head of Chemical Development and Engineering at Sanofi and Sean Bermingham, Head of Formulated Products at PSE Ltd
27th September 2021


Next Generation Bioprocess Facility Design – A Case Study From Samsung Biologics

Presented by Ken Green, Ph.D, Head of Manufacturing, Science and Technology at Samsung Biologics and John Bonham-Carter. Product Line Leader, Cell Culture & Clarification Business, Repligen
26th October 2020


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia